Canada's Drug Agency | Homepage

We are Canada's Drug Agency

Learn more

We’re Officially Launching Canada’s Drug Agency

Read more about We’re Officially Launching Canada’s Drug Agency

New Guidance Aims to Inform Aging-in-Place Initiatives

Read more about New Guidance Aims to Inform Aging-in-Place Initiatives

Understanding the Rare Disease Registries Landscape in Canada

Read more about Understanding the Rare Disease Registries Landscape in Canada

Featured Reports

All Reports
All Reports

Powering evidence-informed drug and health technology decisions for sustainable, world-class health care for all

We are experts at finding, interpreting, and assembling the best available information, and we know that evidence is the foundation of good decision-making.

Learn More

A National Capital Region’s top employer

We are proud and excited to share that our organization has been named one of the National Capital Region's top employers for 2024.

Read More

Latest News

All News

New Flexible Service Through Our Scientific Advice Program

Drug sponsors can now request a flexible service through our Scientific Advice program that can include a shorter time frame. For Scientific Advice ...

New Guidance Aims to Inform Aging-in-Place Initiatives

Canada’s Drug Agency has released new guidance around aging in place. This guidance is intended to help health systems address Canada’s demographic ...

We’re Officially Launching Canada’s Drug Agency

Today’s the day: we are officially Canada’s Drug Agency. We are expanding on our existing mandate and functions — which span drugs, medical devices ...

Understanding the Rare Disease Registries Landscape in Canada

Canada’s Drug Agency has published a national inventory of rare disease registries (RDRs) that includes both registries in Canada and international ...

Meet Canada’s Outstanding Leaders in Health Technology Assessment

Canada’s Drug Agency is pleased to announce the recipients of our 2024 Recognition Awards. These awards honour individuals who are pushing the science ...

Strategies to Reduce Alternate Level of Care in Canadian Hospitals

A new Environmental Scan from Canada’s Drug Agency examines Canadian data related to alternate level of care (ALC) and the effectiveness of strategies ...
All News

Canada’s Drug Agency

Canada’s Drug Agency is a pan-Canadian health organization.

Created and funded by Canada’s federal, provincial, and territorial governments, we’re responsible for driving better coordination, alignment, and public value within Canada’s drug and health technology landscape.

We provide Canada’s health system leaders with independent evidence and advice so they can make informed drug, health technology, and health system decisions, and we collaborate with national and international partners to enhance our collective impact. 

Upcoming Events

All Events
No upcoming events
All Events
postcard

Canada’s Drug Agency recognizes the traditional territories, rights, and diversity of all First Nations, Inuit, and Métis communities across Canada. Indigenous Peoples have been, and continue to be, excluded from and harmed by Canada’s health care systems. In the spirit of reconciliation, we are committed to addressing these inequities alongside Indigenous communities.